SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-000748
Filing Date
2022-01-03
Accepted
2022-01-03 17:30:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d246221d424b5.htm 424B5 639258
2 GRAPHIC g246221g22x14.jpg GRAPHIC 135006
3 GRAPHIC g246221g73u99.jpg GRAPHIC 38276
  Complete submission text file 0001193125-22-000748.txt   874878
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-235817 | Film No.: 22503227
SIC: 2834 Pharmaceutical Preparations